These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25456832)

  • 21. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.
    You J; Zhang P; Hu F; Du Y; Yuan H; Zhu J; Wang Z; Zhou J; Li C
    Pharm Res; 2014 Mar; 31(3):554-65. PubMed ID: 24022681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
    VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
    J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
    Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
    Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes.
    Dicheva BM; ten Hagen TL; Schipper D; Seynhaeve AL; van Rhoon GC; Eggermont AM; Koning GA
    J Control Release; 2014 Dec; 195():37-48. PubMed ID: 25176578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.
    Li Q; Tang Q; Zhang P; Wang Z; Zhao T; Zhou J; Li H; Ding Q; Li W; Hu F; Du Y; Yuan H; Chen S; Gao J; Zhan J; You J
    Biomaterials; 2015 Jul; 57():1-11. PubMed ID: 25956192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted magnetic liposomes loaded with doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2010; 605():279-93. PubMed ID: 20072888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of DNA damage in Ehlrich carcinoma after treatment with doxorubicin encapsulated in nanoscales thermosensitive liposomes in combination with localized hyperthermia.
    Rageh MM; Shafaa MW; Elhefnawy MR; El-Nagdy MS
    Gen Physiol Biophys; 2016 Jul; 35(3):311-22. PubMed ID: 27174899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer.
    Lokerse WJM; Bolkestein M; Dalm SU; Eggermont AMM; de Jong M; Grüll H; Koning GA
    J Control Release; 2017 Jul; 258():34-42. PubMed ID: 28479096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
    Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
    Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
    Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
    Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.
    Gasselhuber A; Dreher MR; Partanen A; Yarmolenko PS; Woods D; Wood BJ; Haemmerich D
    Int J Hyperthermia; 2012; 28(4):337-48. PubMed ID: 22621735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive liposomes.
    Bredlau AL; Motamarry A; Chen C; McCrackin MA; Helke K; Armeson KE; Bynum K; Broome AM; Haemmerich D
    Drug Deliv; 2018 Nov; 25(1):973-984. PubMed ID: 29688083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.
    Gasselhuber A; Dreher MR; Rattay F; Wood BJ; Haemmerich D
    PLoS One; 2012; 7(10):e47453. PubMed ID: 23082168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
    Guo F; Yu M; Wang J; Tan F; Li N
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.